This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Carol J. MacArthur, MD; Craig W. Senders, MD; Jacob Katz, MD

Arch Otolaryngol Head Neck Surg. 1995;121(6):690-693.

Abstract
Hemangiomas common benign neoplasm in the neonatal period. While most small hemangiomas involute spontaneously, up to 20% may grow to a massive size and never completely involute. Massive hemangiomas are also frequently associated with life-threatening complications, such as airway obstruction, platelet trapping (Kasabach-Merritt syndrome), and high-output heart failure. The use of interferon alfa-2a for the treatment of massive hemangiomas not responsive to traditional therapy has recently been reported. We present the successful use of interferon alfa-2a in a series of five patients with massive hemangiomas complicated by airway compromise, congestive heart failure, need for tracheotomy, Kasabach-Merritt syndrome, and failure to thrive, despite traditional therapy.

(Arch Otolaryngol Head Neck Surg. 1995;121:690-693)

Author Affiliations
From the Departments of Otolaryngology—Head and Neck Surgery, University of California, Irvine (Dr MacArthur), and University of California, Davis (Sacramento) (Dr Senders), and the Division of Hematology/Oncology, Department of Pediatrics, University of California, Irvine (Dr Katz).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hemangiomas of Infancy: Clinical and Biological Characteristics
Smolinski and Yan
CLIN PEDIATR 2005;44:747-766.
ABSTRACT  

The Application of the Potassium-Titanyl-Phosphate (KTP) Laser in the Management of Subglottic Hemangioma
Madgy et al.
Arch Otolaryngol Head Neck Surg 2001;127:47-50.
ABSTRACT | FULL TEXT  

Antiangiogenic Therapy of a Recurrent Giant Cell Tumor of the Mandible With Interferon Alfa-2a
Kaban et al.
Pediatrics 1999;103:1145-1149.
ABSTRACT | FULL TEXT  

An Update on the Treatment of Hemangiomas in Children With Interferon Alfa-2a
Greinwald et al.
Arch Otolaryngol Head Neck Surg 1999;125:21-27.
ABSTRACT | FULL TEXT  

The Response of Parotid Hemangiomas to the Use of Systemic Interferon Alfa-2a or Corticosteroids
Blei et al.
Arch Otolaryngol Head Neck Surg 1997;123:841-844.
ABSTRACT